Sanders targets pharma CEOs to testify in Senate, but some see 'retaliation' for lawsuit against Biden admin

Sen. Bernie Sanders plans a Jan. 31 vote to subpoena Pharma CEOs for a drug pricing hearing after they declined last year, citing "unacceptable" refusal and questioning high costs compared to other countries.